Dose Cancer Research Results
Dose, Dosage: Click to Expand ⟱
| Source: |
| Type: |
Drug dosage vs efficacy, and actual dosage number of research papers.
|
Lung, Lung Cancer: Click to Expand ⟱
Lung CSC (Cancer Stem Cells) markers (CD133, CD44, ALDHA1, Nanog and Oct4)
|
Scientific Papers found: Click to Expand⟱
TrxR↓, Dose↝, RadioS↑, ChemoSen↑, ROS↑, Diff↑, toxicity↓,
TrxR↓, eff↑, Dose↝, OS↑, eff↑,
12LOX↓, Dose↝, TumCCA↑, CDK1↓, CycB/CCNB1↓, Apoptosis↑, Bcl-2↓, P53↑, BAX↑, TumCP↓,
| - |
vitro+vivo, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Nor, |
BEAS-2B |
|
|
|
- |
in-vitro, |
Lung, |
PC9 |
|
|
|
Dose↝, mt-ROS↑, p‑JNK↑, BAX↑, Cyt‑c↑, Casp↑, AntiTum↑, ER Stress↑, LDH↑, selectivity↑, Apoptosis↑, DNAdam↑, IRE1↑, XBP-1↑, CHOP↓, p‑eIF2α↓, GRP78/BiP↓, Ca+2↑, MMP↓, Bcl-2↓, Casp3↑, Casp9↑, eff↓, TumW↓, Weight↑, eff↑, eff↑,
| - |
in-vitro, |
Lung, |
H1299 |
|
|
|
- |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Pca, |
PC3 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
Glycolysis↓, GlucoseCon↓, lactateProd↓, PKM2↓, mTOR↓, Hif1a↓, selectivity↑, Dose↝, tumCV↓,
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Cerv, |
HeLa |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
TrxR↓, Dose↝, eff↑,
CD8+↑, OS↑, eff↝, CoQ10↑, PDT+↓, PGC-1α↑, Dose↝, *toxicity∅,
TumVol↓, OS↑, Dose↝, Dose↝, CEA↓, CA125↓, CYFRA21-1↓, SIRT1↓, COX2↓, IL1β↓, IL6↓, TNF-α↓, HMGB1↓, NF-kB↓, EP2↓,
SIRT1↑, Dose↝, TumCP⇅, Ferroptosis↑, lipid-P↑, AMPK↑, ACC↑,
Showing Research Papers: 1 to 9 of 9
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 9
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
CoQ10↑, 1, Ferroptosis↑, 1, lipid-P↑, 1, ROS↑, 1, mt-ROS↑, 1, TrxR↓, 3,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1, PGC-1α↑, 1,
Core Metabolism/Glycolysis ⓘ
12LOX↓, 1, ACC↑, 1, AMPK↑, 1, GlucoseCon↓, 1, Glycolysis↓, 1, lactateProd↓, 1, LDH↑, 1, PKM2↓, 1, SIRT1↓, 1, SIRT1↑, 1,
Cell Death ⓘ
Apoptosis↑, 2, BAX↑, 2, Bcl-2↓, 2, Casp↑, 1, Casp3↑, 1, Casp9↑, 1, Cyt‑c↑, 1, Ferroptosis↑, 1, p‑JNK↑, 1,
Transcription & Epigenetics ⓘ
tumCV↓, 1,
Protein Folding & ER Stress ⓘ
CHOP↓, 1, p‑eIF2α↓, 1, ER Stress↑, 1, GRP78/BiP↓, 1, IRE1↑, 1, XBP-1↑, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 1, P53↑, 1,
Cell Cycle & Senescence ⓘ
CDK1↓, 1, CycB/CCNB1↓, 1, TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
Diff↑, 1, EP2↓, 1, mTOR↓, 1,
Migration ⓘ
Ca+2↑, 1, CEA↓, 1, TumCP↓, 1, TumCP⇅, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1,
Immune & Inflammatory Signaling ⓘ
COX2↓, 1, HMGB1↓, 1, IL1β↓, 1, IL6↓, 1, NF-kB↓, 1, PDT+↓, 1, TNF-α↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 1, Dose↝, 10, eff↓, 1, eff↑, 5, eff↝, 1, RadioS↑, 1, selectivity↑, 2,
Clinical Biomarkers ⓘ
CA125↓, 1, CEA↓, 1, CYFRA21-1↓, 1, IL6↓, 1, LDH↑, 1,
Functional Outcomes ⓘ
AntiTum↑, 1, OS↑, 3, toxicity↓, 1, TumVol↓, 1, TumW↓, 1, Weight↑, 1,
Infection & Microbiome ⓘ
CD8+↑, 1,
Total Targets: 73
Pathway results for Effect on Normal Cells:
Functional Outcomes ⓘ
toxicity∅, 1,
Total Targets: 1
Scientific Paper Hit Count for: Dose, Dosage
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:15 Cells:% prod#:% Target#:1114 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page